EXECUTIVE SUMMARY
The SCMPMD was asked to
provide an opinion on the
equivalency of alternative
products to intestines of
animal origin for use as
surgical sutures. Specifically
the Committee was asked for an
opinion on whether such
alternative products represent
an equivalent or satisfactory
alternative to catgut in
relation to safety and
performance. Moreover the
Committee was asked to specify
under which conditions would it
be acceptable to use animal
tissues for the manufacture of
sutures, taking in account that
currently available
inactivation procedures for
viral and non-conventional
transmissible agents may not be
used as they adversely affect
the mechanical characteristics
and functionality of the
suture.
The report of the
Committee provides the opinion
that there are sufficient
synthetic alternative products
to catgut suture that provide
equal, or even better clinical
performance than catgut and
that there are no clinical
indications for the preferred
use of catgut. The Committee
recognises that there has been
a diminishing use of catgut
sutures during the last decade,
that the decrease is likely to
continue and that there is, in
fact, no further need for
catgut sutures from the
clinical point of view.
With respect to any continued commercial supply of catgut sutures, the Committee is of the view that, in the light of the bovine and ovine origin of the material, and the classification of intestines as tissues of medium infectivity,special conditions have to be met in order to manage the risks related to TSE. Since there are no known inactivation processes that can be applied to catgut, risk management cannot be achieved by this method. The Committee is of the opinion that risk management could only be addressed through the sourcing of material from BSE-free areas, coupled with the use of processing methods that involve a controlled system of collection and handling in order to prevent cross contamination. Specifically, in the case of any continued production of catgut, the manufacturing process should be in conformity with the guidelines set forth in appropriate standards and guidance documents from the Commission.
The Committee draws
special attention to the
requirement within the
regulatory procedure for
medical devices for
justification to be provided
when using animal tissues in
situations where satisfactory
alternative materials are
available. It is the opinion of
the Committee that the
Commission should specifically
inform the relevant Competent
Authorities and Notified Bodies
of this point with the
recommendation that all CE
marked catgut suture products
be reassessed in this light.
REPORT
Terms of reference
The Committee was
requested by DG III of the
European Commission to give a
response to the following
questions;
In the specific case of
surgical sutures manufactured
using intestine of animal
origin (bovine and ovine), do
the alternate products present
an equivalent or satisfactory
alternative in relation to
safety and performance?
Under which conditions
would it be acceptable to use
such materials for the
manufacture of sutures taking
into account that currently
available inactivation
procedures for viral and
non-conventional transmissible
agents may not be used as they
adversely affect the mechanical
characteristics and
functionality of the suture?
Background
The background to this request is that a wide variety of surgical sutures is currently available, including examples of both absorbable and non-absorbable materials, either of natural or synthetic origin, all of which have given perfectly acceptable performance for many years in surgical practice. Sutures themselves are not normally considered to be a risk factor in surgery and although there are differences between them in characteristics, they are all considered to be intrinsically safe. Catgut is a material derived from the intestines of either sheep or cows and has been used as an absorbable suture material for over a century. Until the questions over transmissible infective agents related to the use of animal tissues in medical devices were raised in recent years, there have been no concerns over the biological safety of catgut. The question must now be raised, however, that if there is any risk of transmission of disease to surgical patients arising from the use of catgut, are there any alternative materials that may be used for all surgical procedures that currently employ catgut which have appropriate properties such that no patient would be disadvantaged or put to any greater risk? An analysis of these risks and risk / benefit ratios must take into account the changes to the properties and performance of catgut that would arise if the tissues from which it is sourced were treated with inactivation procedures for viral and non-conventional transmissible agents.
The Nature of Absorbable
Suture Materials
Absorbable sutures are
used for all surgical
procedures in which deep layers
of connective tissue have to be
closed following trauma or
surgery, where it is desirable
for the material to degrade and
be absorbed by the tissues of
the body over time. It is
imperative that the material
retains its strength for a
reasonable length of time
(typically 14 - 21 days), such
that the tissues are held
together while wound healing
takes place, and then resorbs
over a further period of time,
this usually being achieved
within 6 months.
Absorbable materials may be either natural or synthetic. Catgut is the only significant example of a natural absorbable suture material in use today. It is a collagen-rich tissue derived from the submucosal fibrous tissue of sheep intestine or the serosal connective tissue layer of bovine intestine. The tissue is mechanically separated and cleaned, chemically treated to cross-link the collagen, typically with formaldehyde or chromium salts, and the resulting fibres are stretched and formed into a monofilament suture. The mechanical properties of catgut are ideal for most surgical applications. The rate of loss of strength varies from site to site depending on conditions, especially as the absorption process requires enzymatic activity (1), but typically the sutures will lose their strength over a 28 day period and will be completely absorbed within a few months (2). The tissue reaction to catgut is quite marked, with significant inflammatory cell activity associated with the material. This, however, is not considered detrimental to the wound healing process.
Synthetic alternatives
to catgut have been available
for over 20 years (3). There
are several forms, all of the
major varieties being made from
aliphatic polyesters,
principally polyglycolic acid,
co-polymers of glycolic and
lactic acid and polydioxanone
(4). These may be either
monofilament or multifilament
and between them provide a
range of characteristics that
cover all functional
requirements for absorbable
sutures. Most synthetic
absorbable sutures degrade
slightly slower than catgut,
although some, for example
those based on polydioxanone,
have significantly slower
degradation profiles. Most are
also associated with a lesser
inflammatory reaction. The
degradation and absorption
processes arise through
hydrolysis and do not vary very
much from site to site in the
body.
A Comparison Between
Catgut and Synthetic Absorbable
Suture Materials
The following is an
assessment of the relative
merits of these two groups of
material. It is emphasised that
comparisons may be made both on
firm objective grounds from
scientific considerations, and
also from an assessment of
clinical merits and other
factors, which may be more
subjective but nevertheless
have to be considered.
Mechanically there can be no doubt that synthetic suture materials can provide performance which is usually better than that provided by catgut and which at the very least is as good as catgut, with one exception mentioned below. By the very nature of the manufacturing process, synthetic materials are more consistent and reproducible in their quality and the batch to batch variation inherent in catgut is not seen. The range of strengths and absorption characteristics are entirely adequate for current surgical procedures. Moreover there are no surgical procedures which can be performed with catgut and which are inappropriate for synthetic sutures. On the contrary there are some procedures where the variability or unpredictability of the degradation of catgut, as pointed out by Tian et al (5) in the case of the stomach for example, makes it an inappropriate material. In terms of direct comparisons, Perey and Watier (6) found far better retention of strength with polyglycolic acid than with catgut, a conclusion also reached by Howes (7) who demonstrated slower and more consistent loss of strength with the polyglycolic acid and generally fewer complications. Postlethwait reported that two synthetic absorbable suture materials lost strength far more consistently than catgut in the stomach and duodenum (8) Herrman has published several papers in which the superiority of synthetic materials over catgut was reported with respect to the mechanical properties (9).
With respect to the tissue reaction, there is widespread agreement that there is usually less tissue reaction around synthetic sutures than around catgut. For example Wainstein et al have recently reported on the inflammation associated with catgut compared to several synthetic absorbable materials in a pyleoplasty model and found the most extensive tissue reaction with the catgut (10). This is consistent with many other observations in the literature. Whether a lower degree of inflammation gives better clinical performance is not always obvious. Bakkum et al (11) have shown differences in the inflammatory reaction to sutures placed in the peritoneum of rats, this increasing from synthetic non absorbable to synthetic absorbable and to catgut as expected, but could not see any correlation with clinical performance parameters such as post-surgical adhesions. On the other hand, Ketcham et al (12) have shown that the greater tissue reaction to catgut than to polyglycolic acid does give poorer clinical performance in the case of episiotomy repair, and Hanke et al (13) have shown reduced levels of cysts and other complications when synthetic sutures rather than catgut was used in the urinary tract. A contrary view has been expressed by Parivar et al (14), however, as they found better clinical results (shorter healing times and marginally fewer complications) when catgut was used in radical retropubic prostatectomy. Although not being able to demonstrate any histological differences between silk and catgut sutures, Kawakami et al (15) did show some functional neurological disturbances in an animal model of lumbar radiculopathy using chromic catgut which they associated with adverse effects of the degradation products of chromic catgut sutures on nerve tissue.
One of the main issues
with catgut concerns infection.
The degradation of catgut
occurs much faster in infected
sites, which could influence
the clinical outcomes, whereas
synthetic sutures are far less
affected (16). Also catgut
sutures appear to be associated
with a greater risk of
infection, possibly because of
a greater degree of bacterial
adhesion and the higher
potential to serve as a focus
for secondary infection (17).
Tobin (18) has stated that
catgut sutures are a poor
choice for use in contaminated
wounds', and this position is
consistently confirmed in the
literature.
The one area where
catgut does appear to have an
advantage over synthetic
materials is that of knot
strength. Catgut is often
considered easier to knot, and
although this is not easy to
quantify, knots do appear to
hold well with less risk of
slippage. There has been a
subjective view in some places
that this leads to less
dehiscence although objective
studies such as that of Clark
et al (19), in which 55% of
catgut-closed colonic
anastomoses showed evidence of
dehisecence compared to 24%
with polyglycolic acid sutures,
tend to demonstrate the
reverse. It is also a clinical
impression that braided
synthetic sutures have a
greater tendency to tear
through oedematous or fragile
tissues or parenchymatous
organs.
Clinical Preferences
As noted below, catgut
sutures have become less and
less popular amongst surgeons
over the last decade. Ten years
ago catgut comprised
approximately 20% of the sale
of sutures in Europe. This
figure has now dropped to about
7% and there is a clear
downward trend (20). Overall,
probably less than 10% of
surgeons use catgut routinely
and the vast majority of these
will be older surgeons who
trained at a time when it was
the only absorbable suture
available. In most advanced
countries all younger surgeons
will exclusively use synthetic
materials. In certain clinical
disciplines, such as
gynaecology, there is a strong
opinion against the continued
use of catgut.
Laufman and Rubel have discussed the preferences for absorbable suture materials with respect to individual properties and clinical speciality (21). In relation to abdominal operations they quote Haxton et al (22) who determined that because of the wound dehiscence and infection problems, the substitution of synthetic materials for catgut would lead to a much reduced incidence of complications. As reported by Blau et al (23), many ophthalmological procedures benefit from the availability of synthetics over catgut, for example in strabismus procedures. Similarly, polyglycolic acid sutures have been shown to be superior with respect to postoperative pain, oedema, infections and other complications in anorectal procedures such as hemorrhoidectomies (24). Chusak and Dibbell have also demonstrated the considerable superiority of polydioxanone in plastic surgery (25). There are many other reports in the clinical literature confirming the clinical superiority of the synthetic absorbable materials and it is not uncommon to see in authoritative textbooks on surgical technique over the last decade the statement that there is little place for catgut in modern surgery' (26).
Manufacturing
Considerations
processes, it would not be a
straightforward matter for a
manufacturer of catgut sutures
with no previous synthetic
suture products to change
production to synthetic
sutures.
Transmissible Spongiform
Encephalopathies in Relation to
Catgut
Since catgut is derived
from bovine or ovine intestinal
tissue, questions concerning
the risk of TSE and other
transmissible infections have
to be raised.
Because catgut sutures
are placed in tissues where the
vascularity is compromised, and
since the catgut is totally
absorbed, there is a strong
possibility of systemic
distribution of any infective
agent present in the material.
Therefore the use of the suture
should be considered almost
equivalent to a parenteral
administration of a substance.
However, based on
current knowledge, there is no
indication of an association
between TSE and catgut sutures.
In the risk assessment
associated with this use, three
principle factors have to be
considered, the geographical
origin of the source, the
infectivity of the tissue in
question and the possibility of
inactivation. In addition, the
quantity of material used in
any one patient and, as noted
above, the route of
administration, may contribute
to the risk of infection.
The issue of TSE risk in
animal tissue is addressed in
European standards (28) which
deal with details of risk
assessment, sourcing and
inactivation.
As far as these three
principle factors are
concerned, the following points
should be noted:
- Intestines are
currently classified as tissues
of medium infectivity.
- The current major
sources are Australia and New
Zealand, considered to be BSE -
free according to the latest
OIE information (28).
- As all inactivation
processes cause severe changes
to catgut, it is not possible
to apply these methods to these
sutures in order to eliminate
infectious agents.
CONCLUSIONS AND
RECOMMENDATIONS
1. The Committee
considers that there are
sufficient alternative products
to catgut sutures, i.e.
synthetic absorbable sutures
made from polymers such as
polyglycolic acid, that provide
equal, or even better, clinical
performance than the catgut.
Apart from considerations of
TSE, there is no difference
between these two types of
sutures with respect to matters
of safety.
2. On the basis of the
considerations in the above
clause, generally there are no
clinical indications for the
preferred use of catgut.
Moreover, scientifically there
is no further need for catgut
sutures. The Committee
recognises that there has been
a diminishing use of catgut
sutures during the last decade
and that this decrease is
likely to continue.
3. Based on
considerations of the bovine
origin and the classification
of intestines as tissues of
medium infectivity, special
conditions have to be met in
order to manage the risks
related to TSE with catgut.
4. In the case of any
continued production of catgut,
the manufacturing process
should be in conformity with
the guidelines set forth in
appropriate standards and
guidance documents from the
Commission, currently in prEN
12442 parts 1,2 and 3, and in
MED.DEV 2.5/5 (29)
5. Since there are no
known inactivation processes
that can be applied to catgut,
risk management cannot be
achieved by this method. Risk
management may only be
addressed through the sourcing
of material from BSE-free
areas, coupled with the use of
processing methods that involve
a contolled system of
collection and handling.
6. The Committee draws
special attention to the
requirement within the
regulatory procedures for
medical devices for
justification to be provided
when using animal tissue in
situations where satisfactory
alternative materials are
available. The relevant
Competent Authorities and
Notified Bodies should be made
aware of this with respect to
the CE mark approval process
for catgut sutures.
Bibliography
1. Salthouse TN,
Williams JA and Willigan DA
(1969) Relationship of cellular
enzyme activity to catgut and
collagen suture absorption.
Surg. Gynaecol. Obstet. 129,
690-699.
2. Salthouse TN (1982)
Biocompatibility of sutures, In
Williams DF, Biocompatibility
in Clinical Practice, Vol. 1,
CRC Press, Boca Raton, 11-33.
3. Herrman JB, Kelly RJ
and Higgins GA (1970)
Polyglycolic acid sutures,
Arch. Surg. 100, 486-490.
4. Amecke B, Bendix D
and Entenmann G (1995)
Synthetic resorbable polymers
based on glycolide, lactide and
similar monomers. In Wise DL et
al Encyclopaedic Handbook of
Biomaterials and
Bioengineering, Part A, Vol. 2,
Dekker, New York, 977-1008.
5. Tian F, Appert HE and
Howard JM (1994) The
disintegration of absorbable
suture materials on exposure to
human digestive juices; an
update. Am.Surg. 60, 287-291.
6. Perey B and Watier A
(1975) Effect of human tissues
on the breaking strength of
catgut and polyglycolic acid
sutures. Chir. Gastroenterol,
9, 87-93.
7. Howes EL (1973)
Strength studies of
polyglycolic acid versus catgut
sutures of the same size. Surg.
Gynecol. Obstet. 137, 15-21.
8. Postlethwait RW
(1975) Rate of breaking
strength loss of absorbable
sutures in the stomach.
Surgery, 78, 531-535.
9. Hermann JB (1973)
Changes in tensile strength and
knot security in surgical
sutures in vivo. Arch. Surg.
106, 707-712.
10. Wainstein M,
Anderson J and Elder JS (1997)
Comparison of effects of suture
materials on wound healing in a
rabbit pyeloplasty model.
Urology, 49, 261-264.
11. Bakkum EA, Dalmeijer
RA, Verdel MJ, Hermans J, van
Blitterswijk CA and Trimbos JB
(1995) Quantitative analysis of
the inflammatory reaction
surrounding sutures commonly
used in operative procedures
and the relation to
post-surgical adhesion
formation. Biomaterials, 16,
1283-1289.
12. Ketcham KR, Pastorek
JG and Letellier (1994)
Episiotomy repair; chromic
versus polyglycolic acid
suture. Southern Med. J. 87,
514-517.
13. Hanke PR, Timm P,
Falk G and Kramer W (1994)
Behavior of different suture
materials in the urinary
bladder of the rabbit with
special reference to wound
healing, epithelialisation and
crystallisation. Urol. Int. 52,
26-33.
14. Parivar F, Fournier
GR and Narayan P (1994)
Urethral anastomotic healing
after radical retropubic
prostatectomy. Urology, 44,
705-709.
15. Kawakami M,
Weinstein JN, Chatani, K,
Spratt KF, Meller ST and
Gebhart GF (1994) Experimental
lumbar radiculopathy .
Behavioral and histologic
changes in a model of radicular
pain after spinal nerve root
irritation with chromic gut
ligatures in the rat. Spine,
19, 1795 - 1802.
16. Williams DF (1980)
The effect of bacteria on
absorbable sutures. J. Biomed.
Mater. Res. 14, 329 - 338.
17. Giardino R, Rocca M,
Fini M, Buscaroli S, Giaveresi
G, Nicoli-Attini N, Bachini F
and Berton C (1992)
Experimental evidence in vitro
and in vivo of the risk of
infection related to the use of
the most commonly used sutures.
Minerva Chir. 47, 1799 - 1805.
18. Tobin GR (1984)
Closure of contaminated wounds.
Surg.Clin.N.Amer. 64, 639-649.
19. Clark CG, Harris J
and Elmasri S (1972)
Polyglycolic acid sutures and
catgut in colonic anastomoses,
Lancet 2, 1006-1008.
20. Data derived from
suture manufacturers, (1998).
21. Laufman H and Rubel
T (1977) Synthetic absorbable
sutures, Surg. Gynaecol.
Obstet. 145, 597-608.
22. Haxton HA, Clegg JF
and Lord M (1974) A comparison
of catgut and polyglycolic
sutures in human abdominal
wounds. J Abdom.Surg. 16,
239-244.
23. Blau RP, Greenberg
S, LorfelR and Sugar JS (1975)
Polyglycolic sutures in
strabismus surgery.
Arch,Ophthalmol. 93, 538-544.
24. Khubchandani IT,
Trimpi HD and Sheets J (1972)
Evaluation of polyglycolic acid
suture vs catgut in closed
hemorrhoidectomy with local
anaesthetic. Southern .Med.J.
67, 1504-1509.
25. Chusak RB and
Dibbell DG (1983) Clinical
experience with polydioxanone
monofilament absorbable sutures
in plastic surgery. Plast.
Reconstr. Surg. 72, 217-220.
26. Kyle J and Coney LC
(1989) Scientific Foundations
of Surgery, Heinemann, Oxford,
p528.
27. Comite Europeen de
Normalisation (1997) Animal
tissues and their derivatives
utilzed in the manufacture of
medical devices, Draft
Standards prEN 12442, Part 1
(Analysis and management of
risk), Part 2 (Sourcing,
controls, collection and
handling) and Part 3
(Validation of the elimination
and/or inactivation of viruses
and other transmissible
agents).
28. World Health
Organisation, Report of Office
International des Epizootie,
OIE, 1998.
29. European Commission
DG III, (1998) Working Document
MEDDEV 2.5/5, Rev 1. Guidelines
on assessment of medical
devices incorporating materials
of animal origin with respect
to viruses and transmissible
agents.